back
SEDI Insider filing browser
| Date | Issuer | Insider | Transaction | Amount | New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
|
|
|---|---|---|---|---|---|---|
| Filed 2024-03-21 11:04 Tx date 2024-03-18 |
$IPA
ImmunoPrecise Antibodies Ltd. |
Roodink, Ilse
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$285.58
+200 vol $1.43 each |
9,542 | |
| Filed 2024-03-21 11:03 Tx date 2024-03-18 |
$IPA
ImmunoPrecise Antibodies Ltd. |
Roodink, Ilse
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$286.00
+200 vol $1.43 each |
9,342 | |
| Filed 2024-03-21 11:03 Tx date 2024-03-18 |
$IPA
ImmunoPrecise Antibodies Ltd. |
Roodink, Ilse
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$7,540
+5,200 vol $1.45 each |
9,142 | |
| Filed 2023-10-03 14:23 Tx date 2023-10-02 |
$IPA
ImmunoPrecise Antibodies Ltd. |
Roodink, Ilse
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$176.00
+100 vol $1.76 each |
3,942 | |
| Filed 2023-10-03 14:23 Tx date 2023-10-02 |
$IPA
ImmunoPrecise Antibodies Ltd. |
Roodink, Ilse
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$184.80
+105 vol $1.76 each |
3,842 | |
| Filed 2023-10-03 14:22 Tx date 2023-10-02 |
$IPA
ImmunoPrecise Antibodies Ltd. |
Roodink, Ilse
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$600.16
+341 vol $1.76 each |
3,737 | |
| Filed 2023-10-03 14:22 Tx date 2023-10-02 |
$IPA
ImmunoPrecise Antibodies Ltd. |
Roodink, Ilse
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$10.56
+6 vol $1.76 each |
3,396 | |
| Filed 2023-10-03 14:21 Tx date 2023-10-02 |
$IPA
ImmunoPrecise Antibodies Ltd. |
Roodink, Ilse
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$84.48
+48 vol $1.76 each |
3,390 | |
| Filed 2023-02-26 01:12 Tx date 2023-02-19 |
$IPA
ImmunoPrecise Antibodies Ltd. |
Roodink, Ilse
5 - Senior Officer of Issuer
Direct Ownership
|
Options Stock Options
50 - Grant of options
|
$164,000
+40,000 vol $4.10 each |
105,000 | |
| Filed 2022-08-01 14:36 Tx date 2022-08-01 |
$IPA
ImmunoPrecise Antibodies Ltd. |
Roodink, Ilse
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$433.00
+100 vol $4.33 each |
3,342 | |
| Filed 2022-08-01 14:36 Tx date 2022-08-01 |
$IPA
ImmunoPrecise Antibodies Ltd. |
Roodink, Ilse
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$385.84
+91 vol $4.24 each |
3,242 | |
| Filed 2022-08-01 14:35 Tx date 2022-08-01 |
$IPA
ImmunoPrecise Antibodies Ltd. |
Roodink, Ilse
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$65.10
+15 vol $4.34 each |
3,151 | |
| Filed 2022-08-01 14:34 Tx date 2022-08-01 |
$IPA
ImmunoPrecise Antibodies Ltd. |
Roodink, Ilse
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$391.98
+94 vol $4.17 each |
3,136 | |
| Filed 2022-08-01 14:34 Tx date 2022-08-01 |
$IPA
ImmunoPrecise Antibodies Ltd. |
Roodink, Ilse
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$8,480
+2,000 vol $4.24 each |
3,042 | |
| Filed 2022-08-01 14:33 Tx date 2022-08-01 |
$IPA
ImmunoPrecise Antibodies Ltd. |
Roodink, Ilse
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$434.00
+100 vol $4.34 each |
1,042 | |
| Filed 2022-04-11 12:01 Tx date 2022-04-11 |
$IPA
ImmunoPrecise Antibodies Ltd. |
Roodink, Ilse
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$5,388
+942 vol $5.72 each |
942 | |
| Filed 2022-04-11 12:00 Tx date 2021-06-02 |
$IPA
ImmunoPrecise Antibodies Ltd. |
Roodink, Ilse
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2022-01-13 12:36 Tx date 2022-01-08 |
$IPA
ImmunoPrecise Antibodies Ltd. |
Roodink, Ilse
5 - Senior Officer of Issuer
Direct Ownership
|
Options Stock Options
50 - Grant of options
|
$397,000
+50,000 vol $7.94 each |
65,000 | |
| Filed 2022-01-13 12:35 Tx date 2021-06-02 |
$IPA
ImmunoPrecise Antibodies Ltd. |
Roodink, Ilse
5 - Senior Officer of Issuer
Direct Ownership
|
Options Stock Options
00 - Opening Balance-Initial SEDI Report
|
15,000 |